China · Delayed Price · Currency is CNY Walvax Biotechnology Statistics
Total Valuation
SHE:300142 has a market cap or net worth of CNY 20.23 billion. The enterprise value is 19.87 billion.
| Market Cap | 20.23B |
| Enterprise Value | 19.87B |
Important Dates
The last earnings date was Saturday, March 28, 2026.
| Earnings Date | Mar 28, 2026 |
| Ex-Dividend Date | Jan 9, 2026 |
Share Statistics
SHE:300142 has 1.60 billion shares outstanding. The number of shares has increased by 0.05% in one year.
| Current Share Class | 1.60B |
| Shares Outstanding | 1.60B |
| Shares Change (YoY) | +0.05% |
| Shares Change (QoQ) | -2.09% |
| Owned by Insiders (%) | 6.33% |
| Owned by Institutions (%) | 14.08% |
| Float | 1.45B |
Valuation Ratios
The trailing PE ratio is 113.86 and the forward PE ratio is 74.41.
| PE Ratio | 113.86 |
| Forward PE | 74.41 |
| PS Ratio | 8.37 |
| PB Ratio | 2.12 |
| P/TBV Ratio | 2.61 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 41.21 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 40.03, with an EV/FCF ratio of -1,067.27.
| EV / Earnings | 111.80 |
| EV / Sales | 8.22 |
| EV / EBITDA | 40.03 |
| EV / EBIT | 190.47 |
| EV / FCF | -1,067.27 |
Financial Position
The company has a current ratio of 2.35, with a Debt / Equity ratio of 0.04.
| Current Ratio | 2.35 |
| Quick Ratio | 2.01 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.78 |
| Debt / FCF | -20.87 |
| Interest Coverage | 115.13 |
Financial Efficiency
Return on equity (ROE) is 1.19% and return on invested capital (ROIC) is 0.88%.
| Return on Equity (ROE) | 1.19% |
| Return on Assets (ROA) | 0.49% |
| Return on Invested Capital (ROIC) | 0.88% |
| Return on Capital Employed (ROCE) | 1.03% |
| Weighted Average Cost of Capital (WACC) | 6.72% |
| Revenue Per Employee | 1.22M |
| Profits Per Employee | 89,723 |
| Employee Count | 1,981 |
| Asset Turnover | 0.18 |
| Inventory Turnover | 0.95 |
Taxes
In the past 12 months, SHE:300142 has paid 40.96 million in taxes.
| Income Tax | 40.96M |
| Effective Tax Rate | 24.66% |
Stock Price Statistics
The stock price has increased by +9.15% in the last 52 weeks. The beta is 0.47, so SHE:300142's price volatility has been lower than the market average.
| Beta (5Y) | 0.47 |
| 52-Week Price Change | +9.15% |
| 50-Day Moving Average | 12.29 |
| 200-Day Moving Average | 11.99 |
| Relative Strength Index (RSI) | 56.27 |
| Average Volume (20 Days) | 43,267,855 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:300142 had revenue of CNY 2.42 billion and earned 177.74 million in profits. Earnings per share was 0.11.
| Revenue | 2.42B |
| Gross Profit | 1.79B |
| Operating Income | 104.33M |
| Pretax Income | 166.11M |
| Net Income | 177.74M |
| EBITDA | 485.60M |
| EBIT | 104.33M |
| Earnings Per Share (EPS) | 0.11 |
Balance Sheet
The company has 1.66 billion in cash and 388.63 million in debt, with a net cash position of 1.28 billion or 0.80 per share.
| Cash & Cash Equivalents | 1.66B |
| Total Debt | 388.63M |
| Net Cash | 1.28B |
| Net Cash Per Share | 0.80 |
| Equity (Book Value) | 9.54B |
| Book Value Per Share | 5.39 |
| Working Capital | 2.61B |
Cash Flow
In the last 12 months, operating cash flow was 490.93 million and capital expenditures -509.54 million, giving a free cash flow of -18.62 million.
| Operating Cash Flow | 490.93M |
| Capital Expenditures | -509.54M |
| Depreciation & Amortization | 381.28M |
| Net Borrowing | -104.72M |
| Free Cash Flow | -18.62M |
| FCF Per Share | -0.01 |
Margins
Gross margin is 73.87%, with operating and profit margins of 4.31% and 7.35%.
| Gross Margin | 73.87% |
| Operating Margin | 4.31% |
| Pretax Margin | 6.87% |
| Profit Margin | 7.35% |
| EBITDA Margin | 20.08% |
| EBIT Margin | 4.31% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.16, which amounts to a dividend yield of 1.23%.
| Dividend Per Share | 0.16 |
| Dividend Yield | 1.23% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 444.39% |
| Buyback Yield | -0.05% |
| Shareholder Yield | 1.21% |
| Earnings Yield | 0.88% |
| FCF Yield | -0.09% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on October 14, 2015. It was a forward split with a ratio of 3.
| Last Split Date | Oct 14, 2015 |
| Split Type | Forward |
| Split Ratio | 3 |
Scores
SHE:300142 has an Altman Z-Score of 5.25 and a Piotroski F-Score of 6.
| Altman Z-Score | 5.25 |
| Piotroski F-Score | 6 |